These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 18704915

  • 1. A safe and effective method to implant a totally implantable access port in patients with synchronous bilateral mastectomies: modified femoral vein approach.
    Chen SY, Lin CH, Chang HM, Hsu HM, Yu JC.
    J Surg Oncol; 2008 Sep 01; 98(3):197-9. PubMed ID: 18704915
    [Abstract] [Full Text] [Related]

  • 2. Editorial regarding use of modified femoral vein approach as method for implanting a totally implantable access port in patients with synchronous bilateral mastectomies (Chen et al.).
    Wanebo HJ.
    J Surg Oncol; 2008 Sep 01; 98(3):147. PubMed ID: 18704913
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Guidewire assisted cephalic vein cutdown for insertion of totally implantable access ports.
    Chang HM, Hsieh HF, Hsu SD, Liao GS, Lin CH, Hsieh CB, Yu JC.
    J Surg Oncol; 2007 Feb 01; 95(2):156-7. PubMed ID: 17262733
    [Abstract] [Full Text] [Related]

  • 6. Use of a totally implantable access port through the external jugular vein when the cephalic vein approach is not feasible.
    Lin YC, Chu CH, Ou KW, Chan DC, Hsieh CB, Chen TW, Hsu HM, Yu JC.
    Ann Vasc Surg; 2011 Feb 01; 25(2):217-21. PubMed ID: 20926248
    [Abstract] [Full Text] [Related]

  • 7. Trigger arrhythmia to confirm the position of totally implantable access ports (TIAP).
    Hsieh HF, Yu JC, Chuang CH, Wu HS, Tsai YC, Lin CH.
    J Surg Oncol; 2007 Oct 01; 96(5):436-7. PubMed ID: 17372925
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Low complication rates with totally implantable access port use in epoprostenol treatment of pulmonary hypertension.
    Dickinson MG, Schölvinck EH, Boonstra A, Vonk-Noordegraaf A, Snijder RJ, Berger RM.
    J Heart Lung Transplant; 2009 Mar 01; 28(3):273-9. PubMed ID: 19285620
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reasons for explantation of totally implantable access ports: a multivariate analysis of 385 consecutive patients.
    Fischer L, Knebel P, Schröder S, Bruckner T, Diener MK, Hennes R, Buhl K, Schmied B, Seiler CM.
    Ann Surg Oncol; 2008 Apr 01; 15(4):1124-9. PubMed ID: 18214621
    [Abstract] [Full Text] [Related]

  • 18. Modification of approach for totally implantable venous access device decreases rate of complications.
    Karanlik H, Kurul S.
    J Surg Oncol; 2009 Sep 01; 100(3):279-83. PubMed ID: 19582820
    [Abstract] [Full Text] [Related]

  • 19. Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients.
    Samaras P, Dold S, Braun J, Kestenholz P, Breitenstein S, Imhof A, Renner C, Stenner-Liewen F, Pestalozzi BC.
    Oncology; 2008 Sep 01; 74(3-4):237-44. PubMed ID: 18716418
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.